Duranftat 200
Medicinal form |
Tablets |
Active ingredient |
|
Concentration |
200mg |
Manufacturer |
|
Price |
11 EGP |
Uses
Peripheral areterial occlusive diseases, stage 11 (intermittent cluadication). Raynaud's phenomenon. Sequelae of stroke, e.g. motor and sensory disorders. Senile dementia, e.g. memory impairment and loss of concentration. Dosage: Itabs. 2:3 times daily.
Dosage
Two Times Per Day
Note: The information provided about this drug does not substitute for consulting a doctor.
Direct Access to Pharmacy Through Innovative Portal
Empower your health journey with Direct Access to Pharmacy Through Innovative Portal - Your gateway to seamless and efficient healthcare solutions at your fingertips
See list pharmacies